MHC peptides over-expressed on prostate cancer cells and methods of use

Details for Australian Patent Application No. 2001275490 (hide)

Event Publications

5 August 2004 Amendment Made

The nature of the amendment is: Amend the name of the applicant from University of Virginia Patent Foundation and Argonex Pharmaceuticals to University of Virginia Patent Foundation. 2002

1 February 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.